Cargando…
Biomimetic Nanotechnology for SARS-CoV-2 Treatment
More than 600 million people worldwide have been infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), resulting in the pandemic of coronavirus disease 2019 (COVID-19). In particular, new waves of COVID-19 caused by emerging SARS-CoV-2 variants pose new health risks to the glob...
Autores principales: | Li, Shuo, Liu, Xue, Liu, Gang, Liu, Chao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10051120/ https://www.ncbi.nlm.nih.gov/pubmed/36992304 http://dx.doi.org/10.3390/v15030596 |
Ejemplares similares
-
SARS-CoV-2 vaccine research and development: Conventional vaccines and biomimetic nanotechnology strategies
por: Huang, Lanxiang, et al.
Publicado: (2021) -
Nanotechnology Integration for SARS-CoV-2 Diagnosis and Treatment: An Approach to Preventing Pandemic
por: Asdaq, Syed Mohammed Basheeruddin, et al.
Publicado: (2021) -
Nanotechnology-based approaches in the fight against SARS-CoV-2
por: Albaz, Alrayan Abass, et al.
Publicado: (2021) -
Nanotechnology-Based Strategies for Effective and Rapid Detection of SARS-CoV-2
por: Moabelo, Koena L., et al.
Publicado: (2021) -
Biomimetic Nanotechnology Vol. 2
por: Gebeshuber, Ille C.
Publicado: (2022)